Novartis Ag Adr Stock Price History
NVS Stock | USD 116.22 1.41 1.23% |
Below is the normalized historical share price chart for Novartis AG ADR extending back to May 11, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novartis stands at 116.22, as last reported on the 11th of October 2024, with the highest price reaching 116.26 and the lowest price hitting 115.50 during the day.
If you're considering investing in Novartis Stock, it is important to understand the factors that can impact its price. Currently, Novartis AG ADR is very steady. Novartis AG ADR has Sharpe Ratio of 0.0833, which conveys that the firm had a 0.0833% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Novartis, which you can use to evaluate the volatility of the firm. Please verify Novartis' Risk Adjusted Performance of 0.0584, downside deviation of 1.36, and Mean Deviation of 0.7104 to check out if the risk estimate we provide is consistent with the expected return of 0.0867%.
At this time, Novartis' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 103.1 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 776.8 M in 2024. . At this time, Novartis' Price To Operating Cash Flows Ratio is comparatively stable compared to the past year. Price To Free Cash Flows Ratio is likely to gain to 19.27 in 2024, whereas Price Earnings Ratio is likely to drop 13.61 in 2024. Novartis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of November 1991 | 200 Day MA 105.6024 | 50 Day MA 115.3464 | Beta 0.498 |
Novartis |
Sharpe Ratio = 0.0833
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | NVS | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.04 actual daily | 9 91% of assets are more volatile |
Expected Return
0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Novartis is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novartis by adding it to a well-diversified portfolio.
Price Book 5.61 | Enterprise Value Ebitda 13.4306 | Price Sales 4.7966 | Shares Float 1.9 B | Dividend Share 3.919 |
Novartis Stock Price History Chart
There are several ways to analyze Novartis Stock price data. The simplest method is using a basic Novartis candlestick price chart, which shows Novartis price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | August 30, 2024 | 120.89 |
Lowest Price | July 19, 2024 | 106.13 |
Novartis October 11, 2024 Stock Price Synopsis
Various analyses of Novartis' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novartis Stock. It can be used to describe the percentage change in the price of Novartis from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novartis Stock.Novartis Price Rate Of Daily Change | 1.01 | |
Novartis Price Daily Balance Of Power | 1.86 | |
Novartis Price Action Indicator | 1.04 | |
Novartis Accumulation Distribution | 7,164 |
Novartis October 11, 2024 Stock Price Analysis
Novartis Stock Price History Data
The price series of Novartis for the period between Sat, Jul 13, 2024 and Fri, Oct 11, 2024 has a statistical range of 14.76 with a coefficient of variation of 3.01. The daily prices for the period are spread out with arithmetic mean of 114.13. The median price for the last 90 days is 114.7. The company underwent 1116:1000 stock split on 9th of April 2019. Novartis AG ADR issued dividends to stockholders on 2024-03-07.Open | High | Low | Close | Volume | ||
10/11/2024 | 115.70 | 116.26 | 115.50 | 116.22 | 1,095,904 | |
10/10/2024 | 115.64 | 115.71 | 114.58 | 114.81 | 762,718 | |
10/09/2024 | 115.14 | 115.72 | 114.97 | 115.64 | 1,330,599 | |
10/08/2024 | 114.12 | 114.19 | 113.55 | 113.77 | 697,183 | |
10/07/2024 | 114.59 | 114.66 | 113.72 | 113.86 | 1,028,949 | |
10/04/2024 | 112.88 | 114.03 | 112.80 | 113.95 | 820,385 | |
10/03/2024 | 115.05 | 115.10 | 113.68 | 113.77 | 1,004,422 | |
10/02/2024 | 114.28 | 114.52 | 113.81 | 114.47 | 825,476 | |
10/01/2024 | 115.00 | 115.04 | 114.11 | 114.55 | 912,856 | |
09/30/2024 | 115.42 | 115.50 | 114.82 | 115.02 | 1,192,498 | |
09/27/2024 | 115.86 | 116.39 | 115.60 | 115.61 | 919,170 | |
09/26/2024 | 115.11 | 115.67 | 114.91 | 115.61 | 845,915 | |
09/25/2024 | 116.84 | 116.95 | 116.42 | 116.43 | 1,046,778 | |
09/24/2024 | 115.84 | 116.48 | 115.43 | 116.42 | 955,866 | |
09/23/2024 | 116.34 | 116.81 | 116.00 | 116.37 | 1,121,960 | |
09/20/2024 | 116.64 | 116.69 | 115.89 | 115.94 | 1,041,495 | |
09/19/2024 | 116.21 | 116.52 | 115.53 | 115.98 | 689,606 | |
09/18/2024 | 116.30 | 116.63 | 115.60 | 115.97 | 771,318 | |
09/17/2024 | 116.10 | 116.10 | 114.98 | 115.70 | 872,317 | |
09/16/2024 | 116.41 | 116.98 | 116.14 | 116.95 | 924,913 | |
09/13/2024 | 115.81 | 116.32 | 115.27 | 115.66 | 1,866,053 | |
09/12/2024 | 115.35 | 115.98 | 114.79 | 115.72 | 1,543,455 | |
09/11/2024 | 114.98 | 115.50 | 113.82 | 115.28 | 1,342,406 | |
09/10/2024 | 117.04 | 117.12 | 116.06 | 116.99 | 954,969 | |
09/09/2024 | 116.88 | 117.76 | 116.78 | 117.16 | 1,185,206 | |
09/06/2024 | 117.24 | 117.60 | 116.62 | 116.65 | 1,151,354 | |
09/05/2024 | 117.74 | 117.85 | 116.33 | 116.49 | 1,317,238 | |
09/04/2024 | 118.29 | 119.43 | 118.29 | 119.38 | 1,160,974 | |
09/03/2024 | 119.13 | 119.44 | 118.27 | 118.50 | 1,155,790 | |
08/30/2024 | 120.37 | 120.92 | 120.06 | 120.89 | 902,634 | |
08/29/2024 | 120.09 | 120.80 | 119.87 | 120.42 | 859,494 | |
08/28/2024 | 120.04 | 120.67 | 119.67 | 119.98 | 860,087 | |
08/27/2024 | 119.45 | 119.91 | 119.26 | 119.84 | 860,940 | |
08/26/2024 | 118.69 | 119.29 | 118.68 | 119.15 | 677,118 | |
08/23/2024 | 117.94 | 118.59 | 117.71 | 118.56 | 801,194 | |
08/22/2024 | 117.96 | 118.15 | 117.61 | 117.76 | 951,496 | |
08/21/2024 | 117.28 | 117.75 | 116.92 | 117.61 | 711,800 | |
08/20/2024 | 116.58 | 117.40 | 116.45 | 117.13 | 1,115,461 | |
08/19/2024 | 115.07 | 116.17 | 114.80 | 115.93 | 857,882 | |
08/16/2024 | 114.63 | 114.91 | 114.18 | 114.70 | 1,057,228 | |
08/15/2024 | 113.55 | 113.66 | 113.06 | 113.31 | 779,885 | |
08/14/2024 | 112.81 | 113.92 | 112.66 | 113.53 | 997,834 | |
08/13/2024 | 111.60 | 112.62 | 111.59 | 112.53 | 1,001,317 | |
08/12/2024 | 111.46 | 111.95 | 111.10 | 111.42 | 925,396 | |
08/09/2024 | 111.56 | 112.16 | 111.51 | 111.89 | 1,037,512 | |
08/08/2024 | 110.60 | 111.46 | 110.48 | 111.02 | 899,782 | |
08/07/2024 | 111.27 | 112.19 | 110.75 | 111.16 | 1,350,838 | |
08/06/2024 | 108.53 | 110.69 | 108.48 | 110.06 | 1,385,000 | |
08/05/2024 | 111.03 | 111.34 | 109.66 | 109.85 | 1,599,331 | |
08/02/2024 | 112.30 | 113.00 | 111.98 | 112.87 | 1,678,907 | |
08/01/2024 | 112.00 | 112.49 | 111.39 | 112.10 | 1,054,493 | |
07/31/2024 | 112.20 | 112.29 | 111.40 | 111.48 | 1,165,220 | |
07/30/2024 | 111.11 | 112.15 | 110.72 | 111.93 | 1,162,022 | |
07/29/2024 | 110.99 | 111.16 | 110.44 | 110.67 | 880,367 | |
07/26/2024 | 110.04 | 110.67 | 109.67 | 110.32 | 858,848 | |
07/25/2024 | 109.38 | 110.51 | 109.36 | 109.93 | 1,248,492 | |
07/24/2024 | 108.25 | 109.79 | 108.15 | 109.29 | 2,212,313 | |
07/23/2024 | 108.12 | 108.15 | 107.23 | 107.70 | 1,319,473 | |
07/22/2024 | 107.96 | 108.75 | 107.59 | 108.73 | 1,468,910 | |
07/19/2024 | 106.35 | 106.53 | 105.72 | 106.13 | 1,683,181 | |
07/18/2024 | 107.81 | 108.29 | 106.67 | 107.22 | 3,460,919 |
About Novartis Stock history
Novartis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novartis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novartis AG ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novartis stock prices may prove useful in developing a viable investing in Novartis
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.1 B | 1.9 B | |
Net Income Applicable To Common Shares | 8 B | 9.8 B |
Novartis Stock Technical Analysis
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
Novartis Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novartis' price direction in advance. Along with the technical and fundamental analysis of Novartis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novartis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0584 | |||
Jensen Alpha | 0.0132 | |||
Total Risk Alpha | (0.06) | |||
Sortino Ratio | (0.02) | |||
Treynor Ratio | 0.1202 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.